Clinical Diagnostics in Patients with Cerebral Infarction Due To Covid-19

The Corona Virus Disease 19 (COVID-19) outbreak is a deadly disease of concern to the world, includingIndonesia. Reported cases death show high number with more than 3800 deaths reported. This diseasecan induce Cytokine Storm Syndrome (CSS) and interfere Blood-Brain Barrier (BBB), causingcoagulopathy hypoxia, which in turn lead cerebral edema brain. research uses casestudy approach, detailed examination one event. In this case, infarction was caused byCOVID-19 as evidenced by laboratory results presence symptoms inflammation, CSF, sepsis,and coagulopathy. These can result hypercoagulability. therapeuticinterventions are carried out reducing edema, preventing secondaryinfection. COVID-19 case have deleterious effect on patients infarction. Propertreatment needed give better results.